A biotech manufacturer that launched its orphan therapy using an exclusive HUB and specialty pharmacy provider engaged our Advisors to support the transition of its service model to a separate HUB with a specialty pharmacy network.
- Collaborated with manufacturer commercial and corporate account teams to develop the new network business model
- Supported development of strategic objectives, program objectives, and business rules
- Our Advisor Subject Matter Expert acted in the capacity as Interim Product Senior Manager/Project Leader at HUB provider
- Conducted operational and IT assessments of HUB provider and developed quality improvement and network connectivity plan
- Made recommendations as to the best approach to “firewall” HUB provider operations from specialty pharmacy operations
- Developed data aggregation, integration, and reporting plan for product HUB/specialty pharmacy network
- Identified data elements and drafted recommended required data sets
- Supported HUB contract development
- Supported specialty pharmacy network contract development
- Supported network contract negotiation and execution support
- Supported network implementation meetings (manufacturer, HUB provider, specialty pharmacy network members)
- Evaluated opportunities to enhance nursing support consistency and data reporting capabilities
- Coordinated and facilitated initial HUB provider and specialty pharmacy network member business reviews